François Bompart
- Infectious Diseases top 5%
- Clinical Biochemistry top 2%
- Epidemiology
- Public Health, Environmental and Occupational Health
- Pharmacology
- Co-authors
- George H. TalbotPeter K. LindenRobert C. MoelleringEmily A. BlumbergJ. F. ReinhardtRay HachemIssam RaadEric Rubinstein
- Topics
- Bacterial Identification and Susceptibility Testing (5 papers)Antimicrobial Resistance in Staphylococcus (5 papers)Viral Infections and Immunology Research (3 papers)
- Journals
- Clinical Infectious DiseasesThe American Journal of MedicineJournal of Antimicrobial Chemotherapy
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
François Bompart
14 papers receiving 383 citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 259
- Clinical Biochemistry 211
- Epidemiology 80
- Public Health, Environmental and Occupational Health 73
- Pharmacology 65
Countries citing papers authored by François Bompart
This map shows the geographic impact of François Bompart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Bompart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Bompart more than expected).
Fields of papers citing papers by François Bompart
This network shows the impact of papers produced by François Bompart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Bompart. The network helps show where François Bompart may publish in the future.
Co-authorship network of co-authors of François Bompart
This figure shows the co-authorship network connecting the top 25 collaborators of François Bompart. A scholar is included among the top collaborators of François Bompart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Bompart. François Bompart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 8 | |
| 3 | 19 | |
| 4 | Vaccination strategies for the last stages of global polio eradication. | 5 |
| 5 | [Vaccination strategies for the global eradication of poliomyelitis]. | 0 |
| 6 | 3 | |
| 7 | 6 | |
| 8 | 69 | |
| 9 | 166 | |
| 10 | 35 | |
| 11 | 36 | |
| 12 | 19 | |
| 13 | 8 | |
| 14 | 31 | |
| 15 | 2 |
About François Bompart
François Bompart is a scholar working on Clinical Biochemistry, Infectious Diseases and Ophthalmology, having authored 15 papers that have together received 412 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Viral Infections and Immunology Research (3 papers). The work is most often cited by research in Clinical Biochemistry (211 citations), Infectious Diseases (259 citations) and Molecular Medicine (62 citations). François Bompart has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include George H. Talbot, Peter K. Linden, Robert C. Moellering, Emily A. Blumberg, J. F. Reinhardt, Ray Hachem, Issam Raad, Eric Rubinstein, John P. Flaherty and Susan J. Rehm. Their work appears in journals such as Clinical Infectious Diseases, The American Journal of Medicine and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.